メキシコ特有の花粉アレルギー市場 – 業界動向と2029年までの予測

メキシコ特有の花粉アレルギー市場の分析と洞察

メキシコ特有の花粉アレルギー市場は、花粉アレルギー反応の有病率の高さ、メキシコでの新薬承認の増加、アレルギーと闘うさまざまな先進療法などの要因によって牽引されており、市場の成長を牽引しています。花粉の空中アレルゲンは市場の機会となり、メキシコの市場を推進する可能性があります。小児人口への影響は、環境条件、土壌の使用の変化、さまざまな花粉シーズン、および治療計画に関するアレルギー専門医の年間データによって異なります。現在、医療費の増加と医薬品市場の成長も市場の成長を推進すると予想されています。アレルギー疾患の有病率は増加しており、診断、治療、および患者間の意識向上のための統合された方法が必要です。膨大な人口がアレルギー疾患に苦しんでおり、大きな負担を生み出しています。アレルギー症例の増加により治療の需要が増加し、予測期間中に市場が大幅に成長すると予想されます。

メキシコ特有の花粉アレルギー市場は、市場プレーヤーの増加と新薬の存在により、予測期間中に成長すると予想されています。これに伴い、メーカーは市場に新製品を投入するための研究開発活動に取り組んでいます。研究開発プログラムの数の増加、革新的で効果的な治療のための新しい開発を促進するための官民パートナーシップの増加は、市場にさらなる影響を与えます。しかし、市場で使用される薬剤の副作用とステロイド薬の誤用は、予測期間中の市場の成長を抑制すると予想されます。しかし、治療費が高いため、患者は高品質で効果的なソリューションを受け入れることが制限されます。今後、治療手順の高コストは、全体的な治療コストに悪影響を及ぼします。さらに、現在

Mexico specific pollen allergies market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyzes opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an analyst brief, our team will help you create a revenue impact solution to achieve your desired goal. The scalability and business expansion of the retail units in the developing countries of various regions and partnership with suppliers for safe distribution of machine and drugs products are the major drivers which propelled the demand of the market in the forecast period.

Mexico specific pollen allergies market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyzes that Mexico specific pollen allergies market will grow at a CAGR of 6.5% during the forecast period of 2022 to 2029.

Market Definition

Allergic diseases are the immunological response of the body to a particulate matter when it invades the body. These include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. Symptoms may include red eyes, an itchy rash, sneezing, a runny nose, shortness of breath, or swelling. These pollens (typically weed pollens) are easily found in the atmosphere in the spring season as well as grass pollens in the summer. Most of the pollen that causes allergic reactions comes from trees, grasses, and weeds. These plants make small, light, and dry pollen grains that travel by air. These are easily found everywhere. Since, it is difficult to completely avoid allergens and therefore, it is crucial to accurately identify the causative antigen for rapid diagnosis and prompt initiation of treatment of allergen immunotherapy. Pollen counts are generally taken with an air-sampling device.

The prevalence of allergic diseases is increasing, which requires an integrated method for diagnosis, treatment and greater awareness among patients. A vast population is suffering from allergic diseases that have generated a significant burden. Rising cases of allergies are expected to increase the demand for treatment, leading to the high growth of the market over the forecast period.

Mexico Specific Pollen Allergies Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of these are discussed in detail below:

Drivers

• Increasing prevalence of allergic disorder

The hypersensitive response of the immune system of an allergic individual to a substance is known as allergic reaction. When an allergen enters the body, it causes the body's immune system to develop an allergic reaction. This reaction can occur when the immune system attacks a normally harmless substance. This can happen in any age, but more frequent in younger age due to the proper functioning of immune response.

Different individuals can be allergic to various allergens, such as pollens allergies among others, which are some of the common allergic reactions. The prevalence of allergic diseases is increasing, which requires an integrated method for diagnosis, treatment and greater awareness among patients. A vast population is suffering from allergic diseases that have generated a significant burden. Rising cases of allergies are expected to increase the demand for treatment, leading to the high growth of the market over the forecast period.

The retrospective studies and recent data on the allergies shows that it is a common disorder in Latin and Central America. Therefore, the market has a great potential for pollen allergic drugs market, which is also going to increase the demand for the product in the forecast period. Thus, increasing prevalence of different kind of allergies is expected to act as driver for the market in the forecast period due to which there will be expected lucrative growth in the market.

• Impact of pollen allergies on pediatric population

Pollen grains are commonly present in the atmosphere that cause various allergic diseases in North America. Pollen aeroallergens can act as opportunity for the market and propel the market in Mexico. The Impact on paediatric population depends on environmental conditions, changes in the use of soil, different pollen seasons, and annual data for allergists in terms of planning the treatment. The increase in forecasted pollen season longer than usual. The growth of the pollen market can be attributed to the increase in the tree pollen season in the country that elicits allergic reactions such as hay fever and rhinitis in the population which is anticipated to drive the market. Pollen in the atmosphere of Mexico city and its impact on the health of the paediatric population.

Hence, prevalence of pollen-induced allergic disease has been increasing with severe symptoms that can be one of the most common health issues affecting adults in Mexico. The prevalence of allergic diseases in Mexico City was 42.6%, allergic rhinitis was the most frequent. Children are the largest age group affected. The highest prevalence was found in Tlahuac country. Coexistence of allergic diseases was found in 19.9%.This is expected to be one of the factors that act as a driver for the Mexico specific pollen allergies market growth in the forecast period.

Opportunity

•  Increase in the environmental pollution

Common air pollutants, such as ozone, sulphur dioxide, and nitrogen dioxide probably act more as irritants than as promoters of sensitization. These pollutants have been shown to be hazardous to adults and children with asthma. Recent studies suggest that prematurely born children are more sensitive to the respiratory effects of outdoor pollution.

Thus, pollution and allergies go hand-in-hand, worsening air and water pollution enables various heavy metals and non-metals an opportunity to come in close contact with skin and respiratory system thus causing allergies. This is increasing the demand for allergy medications.

The increasing air pollution along with water population is expected to increase the prevalence of respiratory and skin allergies, which is expected to increase the demand for the product used for allergy hence it is considered as opportunity for the market.

Restraint/Challenge

• Side effects associated with the use of drugs

Sometimes drugs have some kind of side effects or adverse effects among the population. The treatment of allergic response is a multi-drugs therapy, which has a greater chance of compatibility issue, which can cause the condition to get worse. Corticosteroids are known to lower the resistance to infection, which can make it harder to treat. It induced osteoporosis, steroids induced myopathy, and osteonecrosis are some of the disorders that are seen among those that use corticosteroids. Systemic administration of these drugs are known to increase the fasting blood glucose level, which make it vulnerable for the diabetic patients to use these therapies during allergic reaction, hence limiting the market growth.

Drowsiness, Headache, dry mouth, throat, and/or nose, stomach pain, nausea, mucus thickening, and increased appetite/weight gain are some of the side effects induced in the patient taking anti-histaminic. Among all, the drug induced diseases are mostly seen among those that use corticosteroids therapy for longer period of time. These side effects of the drug is expected to limit the use of drugs hence act as restraint for the growth of the Mexico specific pollen allergies market in the forecast period.

Post COVID-19 Impact on pollen allergies market

The COVID-19 has positively affected in the growth of the market. As there is rise in the demand for products is wide in the region. People have become more health conscious as there is prevalence of various diseases in the region which is also rising. Complications of other allergies due to aggravation are often seen and have become a problem.Hence the COVID-19 has impacted positively on this market.

Recent Developments

• In July 2021, Prestige Consumer Healthcare announced that the company has completed the previously announced acquisition of TheraTears and other over-the-counter consumer brands. This is expected to increase the company’s manufacturing capacity in the U.S. and help in revenue generation.
• In September 2021, EUROIMMUN Medizinische Labordiagnostika AG and Immunodiagnostic Systems (IDS) partnership to cooperate in the fields of research and development, production as well as distribution, and this will help to grow the business and generate revenue.

Mexico Specific Pollen Allergies Market Scope

Mexico specific pollen allergies market is categorized into five notable segments which are based on product type, diagnosis test, product, end users and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Drug Type

• Antihistamines
• Corticosteroids
• Decongestants
• Anticholinergics
• Others

Based on drug type, the market is segmented into antihistamines, corticosteroids, decongestants, anticholinergics and others.

Diagnostic Test

• In Vivo Test
• In Vitro Test

Based on diagnostic test, the market is segmented into in vivo test and in vitro test.

Product

• Instruments
• 試薬とキット
• その他

製品に基づいて、市場は機器、試薬およびキット、その他に分類されます。

エンドユーザー

• 病院
• 診断研究所
• 学術研究機関
• その他

エンドユーザーに基づいて、市場は病院、診断研究所、学術研究機関、その他に分類されます。

流通チャネル

• 直接入札
• 小売販売

流通チャネルに基づいて、市場は病院薬局、小売薬局、その他に分類されます。

メキシコ特有の花粉アレルギー市場の地域分析/洞察

メキシコ特有の花粉アレルギー市場が分析され、上記のように製品タイプ、診断テスト、製品、エンドユーザー、流通チャネル別に市場規模の洞察と傾向が提供されます。

メキシコ特有の花粉アレルギーレポートの対象国はメキシコです。

メキシコ特有の花粉アレルギー市場は、アレルギー疾患の罹患率の上昇により、成長すると予想されています。これは、花粉シーズンが通常よりも長くなっていることを示しています。花粉市場の成長は、国内で木の花粉シーズンが長くなり、国民に花粉症や鼻炎などのアレルギー反応を引き起こすことに起因しており、これが市場を牽引すると予想されています。さらに、医療費の増加と医薬品市場の成長も、市場の成長を促進すると予想されています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える個別の市場影響要因と市場規制の変更も提供しています。下流および上流のバリュー チェーン分析、技術動向、ポーターの 5 つの力の分析、ケース スタディなどのデータ ポイントは、個々の国の市場シナリオを予測するために使用される指標の一部です。また、国別データの予測分析を提供する際には、北米ブランドの存在と可用性、地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、国内関税と貿易ルートの影響も考慮されます。

競争環境とメキシコ特有の花粉アレルギー市場シェア分析

メキシコ特有の花粉アレルギー市場の競争環境は、競合他社による詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、北米でのプレゼンス、生産拠点と施設、生産能力、会社の強みと弱み、製品の発売、製品の幅と広さ、アプリケーションの優位性などがあります。提供されている上記のデータ ポイントは、メキシコ特有の花粉アレルギー市場への企業の重点にのみ関連しています。

この市場で活動している主要企業としては、Siemens Healthcare GmbH、Sanofi、bioMérieux SA、GlaxoSmithKline plc.、Minaris Medical America, Inc.、Quest Diagnostics Incorporated、Circassia、Alcon Inc.、Thermo Fisher Scientific Inc.、Johnson & Johnson SA de CV、Lincoln Diagnostics, Inc.、EUROIMMUN Medizinische Labordiagnostika AG、Bayer Pharmaceuticals、Prestige Consumer Healthcare Inc.、 CINFA LABORATORIES、Perrigo Company plc. などが挙げられます。

研究方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。市場データは、市場統計モデルとコヒーレント モデルを使用して分析および推定されます。さらに、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数の市場への影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。これとは別に、データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、企業市場シェア分析、測定基準、メキシコ対国、ベンダー シェア分析が含まれます。さらに問い合わせる場合は、アナリストへの電話をリクエストしてください。

SKU-69111